Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04980287 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mesogastrium Metastasis in Colon Cancer

StatusRecruiting
PhaseNot specified
SponsorJichao Qin
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 19, 2023 → Jul 19, 2025
See other at-risk trials from Jichao Qin

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 19, 2023 to Jul 19, 2025
    • Study completion pushed from Jul 19, 2026 to Jul 19, 2028
    • Eligibility criteria expanded, about 12 words
    • Site details revised
  2. 2 versions Re-verified since Jan 7, 2023, no change to tracked fieldsv2-v3
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jichao Qin
7 trials monitored
See 1 trial at risk
Colorectal Cancer
3,394 trials monitored
See 159 trials at risk
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Trial Details
NCT Number NCT04980287
Lead Sponsor Jichao Qin
Conditions
(from sponsor)		 Colon Cancer
Related terms Colonic Neoplasms, Neoplasm Metastasis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov